Artificial intelligence (AI) is no longer a fictional dream of the future. It’s here, and it is in use in many unexpected places. It’s shown significant promise in the world of medicine. It’s even found a variety of applications in ophthalmology.
Detecting Diabetic Retinopathy with AI
Diabetic retinopathy can appear without any symptoms. An early diagnosis is critical. Ophthalmologists will be turning to AI technology to help diagnose patients with the FDA-approved IDx-DR analyses eye images that are captured with a retinal camera.
The software recognizes signs of diabetic retinopathy and alerts the doctor that treatment may be needed. A study was published in 2018 in the American Academy of Ophthalmology’s official journal that found that AI can accurately detect the early signs of diabetic retinopathy.
Software Can Detect Macular Degeneration
Macular degeneration is another concern that may not show symptoms until it has progressed. Patients may report blurry vision and a loss of central vision. More than 10 million people in the United States have macular degeneration.
A study was published in the February 2018 edition of Cell Magazine that found AI-based software can identify the signs of macular degeneration. The technology was taught using expert-chosen images. Using these clear diagnostic examples, the software could learn to assist ophthalmologists when evaluating patients. Computer systems also tend to work quickly and with less risk of human error.
Grosinger, Spigelman & Grey is abreast of the most current research available and is trained in the newest technological developments and equipment to bring our patients the best available care possible. Contact our Bloomfield Hills offices today to schedule your eye exam.